Anogenital Warts in a Major Venereology Clinic: Centro de Saúde da Lapa - Lisbon, 2008 to 2014
Keywords:Condylomata Acuminata, Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18, Papillomavirus Infections, Sexually Transmitted Diseases, Viral, Warts.
Introduction: Human papillomavirus infection is the most common sexual transmitted infection in the world, being associated with different diseases, namely anogenital warts, recurrent respiratory papillomatosis and anal, cervical, and oropharyngeal cancers. Among sexually active people, approximately 1% has anogenital warts, 90% of cases resulting from genotypes 6 and 11.
Material and Methods: Patients diagnosed with first episode of anogenital warts from 2008 to 2014 in Lisbon’s major venereology clinic were identified, and characterized according to sex, sexual orientation, age, warts location, and number of sexual partners.
Results: We observed a statistically significant decrease in first anogenital warts diagnosis among < 19 year old females (r = -0.848;
p = 0.016) and a non-statistically significant decrease among < 19 – year-old males and among 20 – 24 year old females.
Discussion: In October 2008, the quadrivalent vaccine (genotypes 6, 11, 16, 18) was introduced in the Portuguese national vaccination program, targeting 13-year-old females, with a catch-up for 17 year old females. In the women´s group, decrease in first anogenital warts diagnosis is probably related to human papillomavirus vaccination before onset of sexual activity.
Conclusion: This study reinforces the importance of national human papillomavirus vaccination program.
How to Cite
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.